Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Huang, Bilian, Zhu, Linjing, Wei, Hongxia, Shi, Haixia, Zhang, Doudou, Yuan, Huanyun, Luan, Linlin, Zheng, Nan, Xu, Shijie, Nawaz, Waqas, Hong, Ying, Wu, Xilin, Wu, Zhiwei
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264373/
https://ncbi.nlm.nih.gov/pubmed/34248960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.678318
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky